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Edited by Richard MaraisAbstract Expression of the gene encoding the MKP-3/Pyst1
protein phosphatase, which inactivates ERK MAPK, is induced
by FGF. However, which intracellular signalling pathway medi-
ates this expression is unclear, with essential roles proposed for
both ERK and PI(3)K in chick embryonic limb. Here, we report
that MKP-3/Pyst1 expression is sensitive to inhibition of ERK
or MAPKK, that endogenous MKP-3/Pyst1 co-localizes with
activated ERK, and expression of MKP-3/Pyst1 in mice lacking
PDK1, an essential mediator of PI(3)K signalling. We conclude
that MKP-3/Pyst1 expression is mediated by ERK activation
and that negative feedback control predominates in limiting the
extent of FGF-induced ERK activity.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The ﬁbroblast growth factors (FGFs) comprise a family of
ligands which initiate one of the most intensely studied and
versatile signal transduction pathways [1]. The requirement
of FGF signalling for cell survival and patterning during limb
and neural embryonic development is well known. Removal of
the apical ectodermal ridge (AER), a tissue source of FGFs in
the limb, leads to truncation, which can be rescued by the
application of beads soaked in FGFs [2]. Conditional mouse
mutants have also demonstrated that FGFs are necessary for
limb growth and patterning [3]. In neural tissue, FGFs pro-
duced by early hypoblast and Hensen’s node are required to
initiate neural induction and for later patterning events in
the neural plate [4].Abbreviations: MKP-3, MAPK phosphatase-3; ERK, extracellular
signal-regulated kinase; MAPK, mitogen activated protein kinase;
FGF, ﬁbroblast growth factor; PI(3)K, phosphatidylinositol-3 kin-
ase; FGFR, FGF receptor; AER, apical ectodermal ridge; PDK1,
3-phosphoinositide-dependent protein kinase 1
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pressed at the cell surface. Clustering of the FGFRs on binding
to FGF ligand and heparan sulphate proteoglycan leads to the
activation of downstream signalling pathways within the cell
[5]. FGFRs can signal through both the extracellular signal-
regulated kinase (ERK) mitogen activated protein kinase
(MAPK) pathway and the phosphatidylinositol-3 kinase
(PI(3)K) signalling pathway, as well as others [6] (Fig. 1).
In embryos it has been found that FGF signalling often in-
duces the expression of genes required to transduce the FGF
signal. For example, FGF-8 induces Pea-3 and Erm expression
in zebraﬁsh and chick, which are known transcription factors
of the FGF pathway [7,8]. In addition, FGFs have been shown
to induce the expression of negative regulators, such as sprouty
and SEF, that act to restrict the output of FGF signalling
[9,10]. We and others have demonstrated that the expression
of the ERK-speciﬁc MAPK phosphatase MKP-3/Pyst1 is in-
duced by FGF signalling, with reports suggesting that two pos-
sible intracellular pathways might be involved [11–17]. This
data has largely been obtained in a range of tissues from diﬀer-
ent model systems, which may explain the diﬀering results ob-
tained. However, in the chick embryonic limb there is a direct
contradiction over which intracellular pathway mediates the
FGF signal. Pharmacological inhibitors of either ERKMAPK
kinase or PI(3)K have been used to invoke these pathways as
essential mediators of MKP-3/Pyst1 expression (Fig. 1)
[11,14]. To resolve this issue, we have used several approaches
in the limb bud and neural plate of embryos, and present new
evidence that MKP-3/Pyst1 regulates ERKMAPK activity via
negative feedback.2. Materials and methods
2.1. Transgenic mice
3-Phosphoinositide-dependent protein kinase 1 (PDK1)/ mice
were generated as described by Lawlor [18]. Whole-mount in situ
hybridisation was carried out at E9.5 using standard techniques and
a murine MKP-3/Pyst1 probe was used as described before [19].
2.2. Pharmacological inhibitors
AG-1X2 (BioRad Laboratories) formate-derivitized beads were
incubated in one of the following inhibitors: 20 mM PD184352, 25
or 50 mM PD098059, and 20 mM LY294002 for 1 h at room temper-
ature. DMSO beads were used as controls. Beads were grafted into
HH22 limb mesenchyme in vivo, or into HH3 neural plate in EC
culture, and incubated for 6 h and 4 h, respectively at 37 C.ation of European Biochemical Societies.
Fig. 1. Pathways downstream of FGF signalling. Downstream of the
FGF tyrosine kinase receptor, the ERK MAP kinase pathway is
activated through Grb2, and the PI(3)K pathway is activated through
Gab1. We have used diﬀerent reagents or mutants to selectively inhibit
key points along both pathways (shown in red); pharmacological
inhibitors PD184352 and PD098059 antagonise MAPK kinase and
reduce ERK MAPK activity; ERK phosphorylation was speciﬁcally
inhibited by expressing a human MKP-3/Pyst1:GFP fusion protein;
LY294002 was used to inhibit PI(3)K signalling and this pathway was
selectively blocked at the level of PDK1 in knock-out mice.
Fig. 2. ERK MAPK activity is eﬀectively repressed with PD184352
and not PD098059. Eﬀects on MKP-3/Pyst1 expression in the neural
plate by two MAPK kinase inhibitors after 4 h. (A) Beads soaked in
20 mM PD184352 decreased MKP-3/Pyst1. (B) DMSO control beads
did not aﬀect expression ofMKP-3/Pyst1. (C) There was no detectable
change in MKP-3/Pyst1 expression with beads soaked in 25 mM
PD098059. The beads are marked with asterisks.
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Distal, medial and proximal pieces were pooled from between 13 and
20 limb buds at stages HH21-23 and snap frozen at 80 C prior to
analysis. Pooled fractions were thawed on ice for 5 min, followed by
centrifugation (Eppendorf centrifuge 13 K for 2 min at 4 C). Excess
media was then removed and samples resuspended in 60 ll of SDS
sample buﬀer followed by heating to 95 C for 3 min and sonication
for 4 s. Samples were then reheated (3 min at 95 C) and cleared by
centrifugation (Eppendorf centrifuge 13 K for 2 min at room tempera-
ture) before analysis using the NuPage electophoresis system (4–12%,
Invitrogen). Following electrophoresis, proteins were transferred to a
0.45 lm polyvinylidene diﬂuoride membrane (Millipore). Immuno-
blotting was then performed using the following antibodies: MKP-3
C20 and tubulin H235 (Santa Cruz), ERK, phospho-ERK and phos-
pho-AKT (S473) (Cell Signalling Technologies). This analysis was per-
formed at least three times with reproducible results and a
representative blot is illustrated.
2.4. Electroporation and RT-PCR
HH21 limbs were microinjected with a mixture of 2 lg/ll hMKP3-
GFP and Fast Green. One platinum electrode was placed to the side
of the limb bud (positive) and another on the neural tube (negative) be-
fore ﬁve 60 V, 50 ms pulses were delivered using a CUY-21 electropo-
rator. Electroporated limbs were identiﬁed by GFP ﬂuorescence and
dissected using a sharpened tungsten needle under UV light. Only tis-
sue that was GFP positive was included for RNA extraction. Approx-
imately 7–13 embryos were collected in four independent experiments
and processed using Qiagen RNA Easy according to the manufac-
turer’s instructions.
Reverse transcription reaction was performed as previously de-
scribed [15]. Brieﬂy, 15 ll of the extracted RNA was heated to 65 C
for 3 min, then cooled on ice. One microliter of reverse transcriptase
was used in a ﬁnal volume of 30 ll and incubated at 42 C for 1 h in
a PCR machine. The cDNA was stored at 20 C. PCR was per-
formed using Taq polymerase from BIOLINE in a total reaction vol-
ume of 30 ll. 5 ll from 30 ll reaction volumes were used in analytical
agarose gels.
cDNA produced from RNA extraction was normalised using
GAPDH primers (forward: 5 0-AGTCATCCCTGAGCTGAATG-3 0
and reverse: 5 0AGGATCAAGTCCACAACAC G-3 0). A linear ampli-
ﬁcation range was provided by using 20, 25 and 30 cycles and an
annealing temperature of 55 C. Chick Mkp-3 speciﬁc primers
(forward: 5 0-ACGTGCGGCCGCATGCTAGATACGTTCAGACC-
CGTC-3 0 and reverse: 5 0-ACGTGAATTCTCACGTGGACTGCAG-
GGAGTCCACC-3 0) were used at 59.8 C annealing temperatureand 35 cycles. GFP (forward: 5v-ACGTGAATTCCTGACCCTGA
AGTTCATCTG-3 0 and reverse: 5 0-ACGTGCGGCCGCGTCTTGA-
AGTTCGCCTTGAT G-30) were used at 55 C annealing temperature
and 30 cycles.3. Results and discussion
Two MAPK kinase inhibitors, PD184352 and PD098059
(Fig. 1), have both been used previously in the chick limb to
address how MKP-3/Pyst1 transcription is regulated, but have
not given consistent results [11,14]. We therefore began by
comparing the eﬀects of these two diﬀerent inhibitors on
MKP-3/Pyst1 transcription. In the chick neural plate as we
have shown previously, beads soaked in 20 mM PD184352
had a clear repressive eﬀect on MKP-3/Pyst1 (Fig. 2A, n = 5/
6) [11]. In contrast, beads soaked in 25 mM (Fig. 2C, n = 6/
6) and 50 mM (data not shown, n = 3/3) of PD098059 had
no detectable eﬀect. Similar results were obtained in the limb
bud. Beads soaked in 20 mM PD184352 inhibited MKP-3/
Pyst1 transcription [11], whereas beads soaked in 50 mM
PD098059 had no eﬀect, even after 20 h (data not shown,
n = 6/6). The failure of PD098059 to inhibit MKP-3/Pyst1
transcription conﬁrms previous results in chick and mouse em-
bryos [12,14]. Since PD184352 is a more soluble, potent and
speciﬁc inhibitor of the MAPK pathway than PD098059, this
may explain the diﬀerent eﬀects of the two drugs [20,21].
Therefore PD183252 appears to be the most reliable tool to
study the MAPK pathway in vivo.
To circumvent problems associated with the use of inhibi-
tors, we manipulated ERK MAPK activity by expressing
MKP-3/Pyst1 itself in the chick limb bud (Fig. 1) [22]. In con-
trast to some other MAPK phosphatases, MKP-3/Pyst1 is
highly speciﬁc for ERKMAPK [22]. In order to distinguish be-
tween ectopic and endogenous MKP-3/Pyst1 transcripts, we
expressed a human MKP-3/Pyst1:GFP fusion protein
(hMKP3-GFP), which inactivates ERK in vivo and in vitro
[11,15], and then used RT-PCR to discriminate between the
human and chick (cMkp-3) mRNAs [15]. This allowed us to
ask whether direct inactivation of ERK MAPK aﬀects
cMkp-3 transcription. After electroporation into HH21 limb
buds, mesenchyme expressing hMKP3-GFP was dissected
from non-transfected tissue under UV ﬂuorescence (Fig. 3A),
Fig. 3. ChickMKP-3/Pyst1 transcription is regulated by ERKMAPK
in the limb bud. Semi-quantitative RT-PCR analyses after electropor-
ation of either GFP control or hMKP3-GFP in the limb bud after 5 h.
(A) hMKP3-GFP ﬂuorescence. (B) RT-PCR was performed on
normalised cDNA to detect cMkp3, GFP and GAPDH. Lane 1:
GFP control. Lane 2: hMKP3-GFP. The transcription of cMkp3 was
inhibited in presence of hMKP3-GFP.
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sults clearly demonstrate that hMKP3-GFP expression sub-
stantially reduced endogenous cMkp-3 transcription when
compared to GFP controls (lanes 1 and 2, Fig. 3B). This is
consistent with ERK MAPK governing MKP-3/Pyst1 expres-
sion in chick limb mesenchyme.
If MKP-3/Pyst1 is regulated in a negative feedback loop,
ERK MAPK must be activated in cells transcribing MKP-3/
Pyst1. To address this, limb bud mesenchyme was separated
from the AER, cut into proximal, middle and distal pieces
(Fig. 4A), and analysed by Western blotting. The active form
of ERK MAPK is phosphorylated on critical threonine and
tyrosine residues, and we used an antibody speciﬁc for this ac-
tive state in our experiments as well as one that detected the
unphosphorylated form of ERK MAPK. In contrast to a pre-
vious report [14], we reproducibly detected phospho-ERK
across the entire limb bud mesenchyme (Fig. 4B). Phospho-
AKT/PKB, a downstream target of the PI(3)K pathway was
also present in this tissue indicating that FGF signalling may
be transduced via either or both of these pathways. Further-
more, MKP-3/Pyst1 protein was present in a distal-to-proxi-
mal gradient, similar to its mRNA expression pattern
(Fig. 4A). In support of our data concerning the presence of
activated ERK in chick limb bud, Corson et al. have also ob-
served a distal-to-proximal gradient of phospho-ERK MAPKFig. 4. Phospho-ERK is detected in limb bud mesenchyme, overlap-
ping with MKP-3/Pyst1. Analysis of phospho-ERK (p-ERK) and
p-AKT levels in three fractions of the limb bud mesenchyme. (A)
Diagram showing limb dissection in relation to MKP-3/Pyst1 tran-
scripts. Mesenchyme cut away from the AER and separated into D,
distal, M, middle, and P, proximal mesenchyme. (B) Western analysis
of extracts of the three regions. p-ERK and p-AKT levels are present
throughout the limb mesenchyme. MKP-3/Pyst1 protein is graded
from distal to proximal, similar to its mRNA expression pattern.
Tubulin served as a loading control.in mouse limb bud mesenchyme using whole-mount immuno-
histochemistry [23]. These results are consistent with the regu-
lation of MKP-3/Pyst1 by phospho-ERK MAPK.
If, as previously suggested in the chick hindlimb and mouse
isthmus, [12,14], MKP-3/Pyst1 expression is regulated by
PI(3)K, this would represent crosstalk between two intracellu-
lar pathways downstream of the FGFR rather than negative
feedback. The PI(3)K antagonist LY294002 (Fig. 1) inhibits
MKP-3/Pyst1 expression in some embryonic tissues [12,14],
but not others [11,15]. We have shown that beads soaked in
LY294002 can attenuate ectopic induction of MKP-3/Pyst1
expression by FGFs in neural plate and limb bud, but a single
bead has no eﬀect on endogenous MKP-3/Pyst1 expression
after short or long incubations in either tissue ([11], data not
shown). We reinvestigated the eﬀects of this drug and found
that endogenous MKP-3/Pyst1 expression could only be re-
duced when two beads soaked in 20 mM LY294002 were co-
implanted into the chick wing bud (Fig. 5A and B, n = 3/3).
However, these high levels of LY294002 possibly inhibited
MKP-3/Pyst1 expression through non-speciﬁc eﬀects.
To probe further the role of PI(3)K, we explored the expres-
sion of MKP-3/Pyst1 in mutant embryos (Fig. 1). Signalling
downstream of PI(3)K is blocked in mice lacking the PDK1 ki-
nase [18]. These mice do not survive after day 9.5, and do not
form limb buds or forebrains [18]. However MKP-3/Pyst1
transcripts were still present in tailbud, caudal neural plateFig. 5. PI(3)K is not responsible for MKP-3/Pyst1 expression in
mouse neural tissue. Expression of MKP-3/Pyst1 in the presence of
beads soaked in PI(3)K inhibitor LY294002 after 6 h. (A) View of the
contralateral control limb showing normalMKP-3/Pyst1 expression in
the limb bud. (B) Loss of MKP-3/Pyst1 transcripts when two beads of
20 mM LY294002 were implanted. (C) MKP-3/Pyst1 expression in
wild-type and PDK1/ embryos at day E9.5. Arrows indicate
persistent MKP-3/Pyst1 expression in anterior neural structures and
in the tail bud.
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n = 4/4). This suggests that PI(3)K is not absolutely required
for MKP-3/Pyst1 expression in these tissues.
We conclude that in the developing limb bud and neural
plate, cells receiving FGF signals co-express MKP-3/Pyst1 to
control ERK MAPK signal gain through a negative feedback
mechanism. This illustrates a fundamental way to shape signal-
ling in biological systems, where the regulators of intracellular
signalling pathways are transcriptionally controlled by their
target pathways [24].
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